Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

FK506 may stimulate hair growth when applied to the skin.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Chrysanthemum zawadskii extract may help treat hair loss by promoting hair growth and affecting growth factors.

Hair loss in black women needs more research, early intervention, and community education.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

The reviewers found the manuscript on inflammation's role in cancer stem cells to be relevant but suggested it needs clarity, more background information, discussion on immune cells' role in tumors, updated references, and grammar corrections.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The reviewers suggest clarifying and expanding on the role of inflammation in stem cell-related cancer development.

The reviewers suggest major revisions for clarity and inclusion of recent findings on inflammation's role in cancer.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

The revised study on how inflammation affects cancer stem cells was accepted after improving clarity and structure.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.